{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.464.1003.196.12.1414",
  "meta" : {
    "versionId" : "2",
    "lastUpdated" : "2019-02-26T22:31:29.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "NCQA PHEMUR Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2022-12-15"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2017-05-04"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.1414",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.464.1003.196.12.1414"
    }
  ],
  "version" : "20170504",
  "name" : "HydrochlorothiazideMethyldopa",
  "title" : "Hydrochlorothiazide / Methyldopa",
  "status" : "active",
  "experimental" : false,
  "date" : "2017-05-04T01:00:13-04:00",
  "publisher" : "NCQA PHEMUR",
  "jurisdiction" : [
    {
      "extension" : [
        {
          "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason",
          "valueString" : "UNKNOWN"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This value set contains concepts that represent glyburide / metformin combination medications.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Ordered.),(Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs (concepts associated with component, form and strength); generic; human use only; prescribable; hydrochlorothiazide / methyldopa (combination medication).),(Exclusion Criteria: Excludes branded drugs; components or ingredient only; non-prescribable; hydrochlorothiazide / methyldopa in combination with other medications.)",
  "compose" : {
    "include" : [
      {
        "valueSet" : [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.1415"
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:3fb3aab5-0c56-4d5e-aab5-dbb204a25025",
    "timestamp" : "2023-06-29T17:52:46-04:00",
    "total" : 2,
    "offset" : 0,
    "parameter" : [
      {
        "name" : "count",
        "valueInteger" : 1000
      },
      {
        "name" : "offset",
        "valueInteger" : 0
      }
    ],
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "06052023",
        "code" : "197960",
        "display" : "hydrochlorothiazide 25 MG / methyldopa 250 MG Oral Tablet"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "06052023",
        "code" : "197963",
        "display" : "hydrochlorothiazide 15 MG / methyldopa 250 MG Oral Tablet"
      }
    ]
  }
}
